Search results
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
Time via Yahoo News· 2 years agoDr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019. Credit - Anastasiia Sapon—The New York...
Guest column: Why new DNA research changes how scientists study disease
The Oklahoman via Yahoo News· 1 year agoThe year is at a stage where it’s pretty much all possibility. Sure, a resolution or two may have...
Bull of the Day: CRISPR Therapeutics (CRSP)
Zacks via Yahoo Finance· 6 months agoCRISPR Therapeutics (CRSP) just made history on Friday with the first FDA-approved gene-editing medicine based on the Nobel Prize-winning discovery that...
Five Best: Books on Breakthroughs in Biology
The Wall Street Journal· 3 weeks agoBOOKSHELF A Crack in Creation By Jennifer A. Doudna and Samuel H. Sternberg (2017) 1. Changing the DNA code in a living organism—to correct a genetic...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via Yahoo News· 1 month agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
InvestorPlace via Yahoo Finance· 1 year agoThe 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work...
FDA Approves First CRISPR Treatment in U.S.
Time via Yahoo News· 6 months agoSickled blood cells forming clumps in a vessel Credit - Getty Images It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier...
Editas cashes in on CRISPR patent with Vertex deal
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Days after winning U.S. approval of the first CRISPR gene-editing medicine, Vertex Pharmaceuticals is clearing up potential intellectual...
The 7 Best Biotech Stocks to Buy
InvestorPlace via Yahoo Finance· 2 years agoI’ve written before about how biotech is the biggest technology trend of our kids’ generation. Naturally, that means many people are looking for the best...
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2...
Business Insider via Yahoo News· 6 months agoThe FDA approved the first gene therapy for sickle cell anemia.Meletios Verras/ iStock The FDA...
